Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

The compounds tested could potentially treat hair loss and alopecia.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Using photoacoustic waves to deliver minoxidil improves hair growth effectively and safely.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Organic selenium may offer better retention and less waste in puppies.

Finasteride may cause slight depression and anxiety.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Storing hair follicles in special buffers with added protective substances can increase hair growth and reduce cell death.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.